Tag: HealthyKids

What Causes Childhood Obesity? Risks and Next Steps

On By Dr. Scott RennieIn Weight Loss & Metabolic HealthLeave a comment

Physicians are seeing the long-term costs of childhood obesity accumulate in real time. Weight percentiles on a growth chart are the smallest part of the picture. Obesity in children is a chronic disease that touches physical development, emotional health, and metabolic trajectory decades out. The American Academy of Pediatrics has been clear that our role reaches past diagnosis into prevention, intervention, and advocacy, starting early and continuing through a child’s development.

For a long time obesity got reduced to a BMI number. BMI says nothing about the biology underneath. Obesity is a disorder of energy homeostasis. Fat cells expand, inflammation increases, hormones shift, and the central nervous system adapts in ways that make weight regulation genuinely hard. The Obesity Medicine Association describes it as a chronic, neurobehavioral disease, and that framing does useful work. It replaces the story about poor choices with a description of physiology meeting environment.

The seeds go in early. Risk factors show up during pregnancy and infancy: maternal obesity, gestational diabetes, formula feeding, rapid weight gain, early introduction of sugar-sweetened beverages. By preschool, adipose tissue in some children already shows inflammation and insulin resistance (Landgraf et al., Diabetes, 2015). Those changes lay groundwork for chronic disease later.

One of the highest-yield conversations is about what children drink. Families rarely realize how much fruit juice and sweetened beverages contribute. Even 100% fruit juice, which reads as the healthy option, behaves metabolically like soda in quantity. High in sugar, stripped of fiber. The AAP recommends no juice in the first year of life, up to 4 ounces daily for ages 1 to 3, 4 to 6 ounces for ages 4 to 6, and no more than 8 ounces for ages 7 to 18. Water and whole fruit are the better answer.

Sugar-sweetened beverages are worse. Soda, sports drinks, flavored teas, and sweetened waters together make up the single largest source of added sugar in children’s diets. Regular consumption tracks with higher calorie intake, greater risk of type 2 diabetes, and higher odds of obesity. Plenty of families keep soda or juice on the table at meals because it is cheap, familiar, or framed as a treat. Shifting toward water, milk, or unsweetened alternatives is one of the few changes that is both simple and consequential.

Activity is the other side. Children under five should be active throughout the day through running, climbing, and unstructured play. From six through seventeen, the recommendation is at least an hour of moderate-to-vigorous activity daily, including aerobic exercise most days plus muscle- and bone-strengthening activity a few times a week. In practice it is harder than it reads. Parents cite safety, cost, and time. Family walks, bike rides, and dance breaks at home aren’t a substitute for a safe neighborhood, but they build habits that carry.

Sedentary behavior deserves its own attention, and this is where the guidance has moved. The old blanket rule of under two hours of screen time a day has been retired. Current AAP guidance emphasizes content quality, co-viewing, and a Family Media Plan built by the household, with roughly one hour a day of high-quality programming for ages 2 to 5 and no screens before 18 months apart from video chat. For older children the useful questions are what the screen is displacing and whether it has become the only way a child settles. Screen-free zones at meals and before bed remain a practical place for families to start.

Environment shapes outcome beyond individual behavior. Children in food-insecure households face higher obesity risk. Limited budgets push families toward calorie-dense, nutrient-poor food. Chronic stress and disrupted routine make it worse. That overlap is why nutrition counseling has to carry an awareness of social determinants alongside it.

Stigma is its own barrier. Children with obesity face bullying and bias from peers, teachers, and health professionals. Weight stigma increases anxiety, depression, and disordered eating, which worsens the condition rather than motivating change (Pont et al., Pediatrics, 2017). Our language matters here. People-first terms like “a child with obesity” rather than “an obese child” reduce shame and preserve trust.

There are real intervention points at every stage. During pregnancy, supporting healthy maternal weight gain and promoting breastfeeding. In early childhood, limiting sugary drinks, protecting sleep and play, establishing routine. In school-age children and adolescents, motivational interviewing and family-based behavioral programs. Even the EHR earns its keep here, prompting screening, flagging comorbidities, and supporting referrals.

Advocacy belongs in the list. Safe neighborhoods, access to nutritious food, and school meal programs shape children’s health at least as much as counseling does.

Childhood obesity is a systemic problem shaped by biology, environment, and society. Failed parenting doesn’t explain it. Our job is to treat compassionately, intervene early, and advocate for healthier environments, and supporting families rather than blaming them is what changes trajectories.

Scott Rennie, D.O.

References:

1. Landgraf K, et al. Evidence of early alterations in adipose tissue biology and function and its association with obesity-related inflammation and insulin resistance in children. Diabetes. 2015;64(4):1249-1261. https://pubmed.ncbi.nlm.nih.gov/25392242/

2. Pont SJ, et al. Stigma Experienced by Children and Adolescents With Obesity. Pediatrics. 2017;140(6):e20173034. https://pubmed.ncbi.nlm.nih.gov/29158228/

3. Heyman MB, Abrams SA; AAP Section on Gastroenterology, Hepatology, and Nutrition and Committee on Nutrition. Fruit Juice in Infants, Children, and Adolescents: Current Recommendations. Pediatrics. 2017;139(6):e20170967. https://pubmed.ncbi.nlm.nih.gov/28562300/

4. American Academy of Pediatrics. Family Media Plan and screen time guidance. https://www.healthychildren.org/English/fmp/Pages/MediaPlan.aspx

Board Certified in Obesity Medicine and Family Medicine

This blog is for educational purposes only and does not constitute individual medical advice. Always consult your own physician before making changes to your health, medications, or treatment plan.

Weight Loss Medications for Kids and Adults Explained

On By Dr. Scott RennieIn Weight Loss & Metabolic HealthLeave a comment

As a physician, I know that treating obesity can be tough. Many families put in real effort with diet and exercise and still don’t see enough progress. When that happens, medication becomes worth discussing. Not for everyone. For the right patient, though, it can make a real difference.

Every price below reflects March 2025, when this was first written, and drug pricing in this class moves constantly, list price, cash price, and whatever a given insurer decides to cover can all diverge sharply, so treat every figure below as a historical marker rather than a current quote.

For children ages 12 and older, there are a few choices. Orlistat, brand name Xenical, blocks fat absorption in the gut. Because it stays in the digestive tract, it doesn’t touch appetite or the brain. The catch is side effects. Eat too much fat on this drug and a kid can get oily stools, gas, frequent bowel movements. A low-fat diet helps. It can still be uncomfortable. The price ran about $50 to $200 a month. The FDA cleared it for ages 12 and up.

Liraglutide, brand name Saxenda, is another option. It mimics a gut hormone called GLP-1, helping with appetite control and slowing stomach emptying. It’s effective, and it also helps blood sugar control, which matters if a patient has insulin resistance. But it requires daily injections, and nausea is common. Vomiting and diarrhea can happen too. Monthly cost usually fell between $1,200 and $1,500 a month. The FDA approved it for kids starting at age 12.

Phentermine combined with topiramate, sold as Qsymia, is approved for adolescents 12 and up who meet obesity criteria. Phentermine reduces appetite. Topiramate curbs cravings. Together they can produce substantial weight loss, especially in patients who struggle with binge eating. Side effects include dry mouth, dizziness, insomnia, and mood changes, and blood pressure and heart rate need regular checks. Cost averaged $200 to $300 a month.

Semaglutide, brand name Wegovy, is another GLP-1 receptor agonist, injected once weekly instead of daily. Clinical studies show it produces impressive weight loss. Side effects mirror other GLP-1 drugs: nausea, vomiting, diarrhea, abdominal pain, constipation. Out-of-pocket cost usually ran $1,300 to $1,600 a month. The FDA approved it for adolescents age 12 and up.

Setmelanotide, or Imcivree, is different from everything above. It targets rare genetic conditions that cause obesity, POMC, PCSK1, or LEPR deficiencies, by restoring hormonal signals that regulate hunger. It’s not meant for most patients, only those with a specific genetic diagnosis. For those who qualify, it can work well. The price tag was steep, though: about $16,000 a month.

For adults, the options broaden, and the prices below are again what things cost in March 2025, not today. Phentermine has been used for decades. It works on the central nervous system to suppress appetite, usually prescribed short-term and paired with diet and exercise. It can be effective, but it may cause insomnia, dry mouth, and a faster heart rate, and it isn’t safe for people with heart disease. The cost was low, around $30 to $60 a month.

Bupropion combined with naltrexone, sold as Contrave, takes a different approach. Bupropion affects brain chemistry to help with appetite and mood. Naltrexone reduces cravings. Some patients feel more energetic on it. Side effects can include nausea, dizziness, and insomnia. Mood changes are possible, so follow-up matters. Cost averaged $200 to $300 a month.

Tirzepatide, marketed as Mounjaro, is one of the newest medications. It activates both GLP-1 and GIP receptors, improving satiety and insulin sensitivity. Given as a weekly injection, it has shown striking results for weight loss. Nausea and diarrhea are the most common side effects, as with other drugs in this class. Costs ran high, around $1,000 to $1,500 a month. At publication it was FDA-approved for type 2 diabetes, not obesity, though already used off-label for weight loss.

A few points cut across all of these. Insurance coverage is unpredictable: some insurers won’t cover these drugs at all, others demand proof that lifestyle efforts were tried first. Close monitoring is essential, because side effects vary. None of these drugs replace healthy habits. They work best stacked on top of diet, activity, and behavior change.

For patients and families, the choices can feel like a lot. Knowing what’s actually available, and what each option costs and asks of you, helps match the right treatment to the right person.

Scott Rennie, D.O.

Sources:

Board Certified in Obesity Medicine and Family Medicine

This blog is for educational purposes only and does not constitute individual medical advice. Always consult your own physician before making changes to your health, medications, or treatment plan.